Notably, tumours with RTK/WNT pathway BRAF and RNF43 co-mutations had higher expression of BRAF and lower expression of RNF43 compared with wild-type tumours and tumours carrying mutations of only one gene (Extended Data Fig. 1a). The gene discussed is RNF43; the disease is neoplasm.